SCHEMBL7982998

SCHEMBL7982998

COc1cc2c(cc1OCC1CCOC1)nc(Nc1c(C)cccc1Cl)c1cncn12

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981422 0.87 LCK (0.73) LCK
SCHEMBL7981621 0.87 LCK (0.73) LCK
SCHEMBL7983263 0.87 LCK (0.75) LCK
SCHEMBL7969720 0.87 LCK (0.72) LCK
SCHEMBL7970084 0.85 LCK (1.00) LCK
SCHEMBL7980325 0.83 LCK (1.00) LCK
SCHEMBL7987001 0.83 LCK (1.00) LCK
SCHEMBL7980248 0.82 LCK (0.84) LCK
SCHEMBL7970742 0.82 LCK (0.93) LCK
SCHEMBL7970062 0.82 LCK (0.83) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed